No Royalties Sample Clauses
The No Royalties clause establishes that one party is not required to pay royalties to the other for the use of certain intellectual property, products, or services covered by the agreement. In practice, this means that the licensee or user can utilize the specified materials without owing ongoing payments based on usage, sales, or revenue generated. This clause is commonly used to simplify financial arrangements and eliminate ongoing payment obligations, thereby reducing administrative burdens and potential disputes over royalty calculations.
POPULAR SAMPLE Copied 30 times
No Royalties. No royalty or similar item or amount is being paid or is owing by Seller, nor is any such item accruing, with respect to the operation, ownership or use of the Business or the Assets.
No Royalties. Neither American (or its Affiliates) nor any Purchasers or Third Party Purchasers shall be required to pay royalties to Licensor, AK, Global or any other Person in connection with the exercise by American or its Affiliates of any of the license rights in the Technology granted under this Agreement.
No Royalties. No royalties or other amounts will be payable by MDT to others as a result of this Agreement or any of the transactions contemplated hereby.
No Royalties. No royalties will be owed by Licensee to Gilead on Licensee’s sale of Product hereunder.
No Royalties. For the avoidance of doubt, neither Party shall have the obligation to pay royalties to the other Party on sales of the Co-Development Product, or to make any payments under the Amendment Agreement with respect to the Co-Development Product.
No Royalties. Neither Covanta (or its Affiliates) nor any Purchasers or Third Party Purchasers shall be required to pay royalties to Licensor, AK, Global or any other Person in connection with the exercise by Covanta or its Affiliates of any of the license rights in the Technology granted under this Agreement.
No Royalties. Grantor hereby agrees that Lender’s right to use the Trademarks as authorized hereunder in connection with Lender’s exercise of its rights and remedies under Section 7 hereof, or under the Loan and Security Agreement shall be co-extensive with Grantor’s rights in and to such Trademarks and Lender shall have no liability to Grantor for royalties or other related charges on account of any such use.
No Royalties. Except with respect to Standard End User Licenses and User Content Licenses and as set forth on Schedule 3.11(j) and the Acacia patent license agreement set forth on Schedule 3.11(j), the Company and its Subsidiaries to the Company’s Knowledge are not required, obligated, or under any liability whatsoever, to make any material payments by way of royalties, fees or otherwise to any owner, licensor of, or other claimant to any IP Assets, or other Person, with respect to the use thereof or in connection with the conduct of the business of the Company and its Subsidiaries, including the Business, in the manner in which it is currently being conducted and was conducted within the twelve (12) months prior to the date of this Agreement and is planned to be conducted by the Company or any of its Subsidiaries.
No Royalties. That the Minerals are not subject to any royalties other than the royalties payable to Tetlin set out herein.
No Royalties. Subject to the Closing, the Assignor releases Pluristem from any obligation to pay to the Assignor any royalties, lump sum payments or other consideration received due to any sublicense granted by Pluristem (“Royalties”) under Section 4 of the License Agreement. The Assignor warrants and represents that as of the date hereof, it shall not raise any claim, allegation and/or assertion with respect to Royalties pursuant to Section 4 of the Agreement, or have any right to Royalties from Pluristem henceforth and/or as otherwise deemed by Assignor as due prior to or following the date hereof, including, without limitation, in connection with the Patent, the Intellectual Property, the Products and/or any derivatives thereof. Pluristem represents that until the date hereof, other than the sublicense with Stem Cells Innovations Inc. no other sublicense transactions were concluded.